As the technology engine behind the multi-use AI-driven platform, Vetscan Imagyst, Techcyte is proud to announce the addition of artificial intelligence (AI) blood smear diagnostics testing. Vetscan Imagyst is Zoetis’s deep learning SaaS platform that uses image analysis to assist veterinary clinics with an accurate and efficient blood differential. Techcyte has collaborated with Zoetis—the world’s [...]

Techcyte has earned ISO 13485:2016 compliance for its quality management system.  When it comes to medical device manufacturing, patient safety greatly depends on the quality and consistency of medical products, and ensuring effectiveness, control and maintenance of quality management systems is critical to customers, patients, users, and regulatory agencies.  The process-based quality management system standard [...]

Digital pathology has long been synonymous with the digitization of histology (tissue-based) samples. Liquid-based samples, however, are notoriously difficult to scan, as the objects of interest are suspended at different focal depths and can be sparse, which makes focusing a challenging task for scanners. Hamamatsu has just announced their partnership with Techcyte where we are [...]

In the most recent episode of the “Digital Pathology Place” podcast, Ben Cahoon, our CEO, talks about the path to innovation that guides their development. Currently, Techcyte algorithms are phase one developments: they count and classify target objects, and present them to skilled operators. In this first phase, automation and accuracy are the goals. An [...]

On August 18th 2021 in Orem, Utah, Techcyte Inc. closed a $21 million funding round to accelerate the commercialization of its digital clinical pathology platform. The investors in this round include Zoetis, ARUP Laboratories and investors from previous rounds. Ben Cahoon, the CEO of Techcyte, said, “Our relationship with Zoetis has been incredible as we’ve [...]

University of Utah, ARUP, and Techcyte Develop NanoSpot.AI, a New Ultra-Fast Test for COVID-19 Antibodies SALT LAKE CITY–The University of Utah (the U), ARUP Laboratories, and Techcyte Inc. announced today that they have formed a partnership to develop NanoSpot.AI, a less than five-minute, easy-to-administer SARS-CoV-2 antibody test. NanoSpot.AI is estimated to be significantly less [...]

FOR IMMEDIATE RELEASE A Whole New Microscopic World: ARUP/Techcyte Publish First Peer-Reviewed Study on AI-based Protozoa Detection June 9, 2020, Lindon, Utah—ARUP Laboratories, a national reference laboratory and worldwide leader in innovative laboratory research and development, and Techcyte, a leading developer of artificial intelligence (AI)-based image analysis solutions for the diagnostics industry, published a study [...]

FOR IMMEDIATE RELEASE Techcyte Secures Patent to Increase Detection of Cancer in Pap Smears The U.S. Patent Office has awarded a patent to Techcyte for automatically detecting objects in pap smears using hidden features and auxiliary ground truth May 21, 2020, Lindon, Utah—Techcyte, a leading developer of AI-based image analysis solutions, announced today that the [...]

FOR IMMEDIATE RELEASE Techcyte Receives a Patent for an AI-based Method to Detect Mold Spores The U.S. Patent Office has awarded Techcyte a patent for a deep learning image analysis-based approach for detecting and classifying mold spores. May 19, 2020, Lindon, Utah—Techcyte, a leading developer of AI-based image analysis solutions, announced today that the U.S. [...]

ARUP Laboratories Deploys World’s First AI-Augmented Ova and Parasite Assay SALT LAKE CITY, August 19, 2019—ARUP Laboratories (ARUP), a national reference laboratory and worldwide leader in innovative laboratory research and development, and Techcyte, a leading developer of artificial intelligence (AI) based image analysis solutions for the diagnostics industry, have developed the world’s first AI-augmented ova [...]